NCT03358888View on ClinicalTrials.gov

Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

June 5, 2017

Primary Completion Date

January 22, 2018

Study Completion Date

February 28, 2018

Conditions
Osteoarthritis, Hip
Interventions
DRUG

Multi-modal with as needed opioids

Multi-modal with as needed oxycodone and tramadol provided for break-through pain

DRUG

Multi-modal with one week of opioids offered

Multi-modal with only one week of oxycodone and tramadol provided for emergency pain relief only

DRUG

Standard of Care

This arm follows standard of care post-operative pain management with oxycodone, tramadol, and acetametophin

Trial Locations (1)

19107

Rothman Institute, Philadelphia

All Listed Sponsors
lead

Rothman Institute Orthopaedics

OTHER

NCT03358888 - Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter